Sulfanilamide

磺胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfanilamide
Drug Alias Name对氨基苯磺酰胺sulfanilamide氨苯磺胺sulfanilamidumsulfanilamida +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial dihydropteroate synthase inhibitors
TargetsBacterial dihydropteroate synthase
Therapy Area/IndicationsVaginosis, BacterialBacterial Infections
Global Approved IndicationsVaginosis, BacterialBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1965/06/05
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Xiao Fang Pharmaceutical Co Ltd
Inactive CompaniesPharmobedient Consulting LLCHoechst Marion Roussel Ltd
Active IndicationsBacterial Infections
Inactive IndicationsVaginosis, Bacterial

Other Information

ATC CodeD06BA05J01EB06
Related LinksWikipediaDrugBankKEGG